Accuray buys Morphormics for $5.7M

Accuray ($ARAY) is moving past its licensing agreement with Morphormics and just buying the company outright, spending $5.7 million to acquire the developer of imaging software.

Morphormics was founded by University of North Carolina at Chapel Hill faculty, and Accuray has licensed its autocontouring imaging technology since 2008 for radiosurgery devices. With the acquisition, Accuray plans to put the software to use in its CyberKnife and TomoTherapy techs, the company said.

"The acquisition of Morphormics will expand Accuray's IP portfolio, reduce our licensing expenses and strengthen our engineering team with top talent from the University of North Carolina at Chapel Hill," Euan Thomson, Accuray's CEO, said in a statement.

The latest acquisition is designed to improve the efficiency of some techs Accuray acquired in its last buyout, a $227 million purchase of TomoTherapy in 2011. That deal brought Accuray the company's eponymous radiation therapy device and spurred sales growth. Since then, the company has partnered with universities in Germany to expand the adoption of CyberKnife, a robotic radiosurgery device.

- read Accuray's statement
- check out MassDevice's take

Suggested Articles

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.

The FDA has announced a series of actions aimed at limiting the use of power morcellators in gynecologic surgeries.

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.